Recent News for ONCE - Spark Therapeutics, Inc.

Date Title
Mar 18 Roche's 'Steep' Spark Buyout Could Put These Gene Therapy Names In Play
Mar 14 Life Sciences Pa. reveals awards for its top CEO, top products and deal of the year
Mar 12 SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Spark Therapeutics, Inc. - ONCE
Mar 10 10 Stocks For The Gene Therapy Revolution
Mar 8 Gene Therapy M&A Has Shares Skyrocketing -- Could This Company Be Next?
Mar 8 Roche's (RHHBY) Tecentriq Gets EC Nod for First-Line NSCLC
Mar 8 Rare Disease Therapies Draw Big Biopharma's Interest
Mar 7 Roche launches tender offer for Spark Therapeutics
Mar 7 Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash
Mar 7 Spark Therapeutics: Elucidating The Roche Acquisition
Mar 6 The Roche Merger Will Do Wonders for Spark Stock
Mar 5 Biogen to Acquire Gene-Therapy Company Nightstar for $800M
Mar 5 Why Spark Therapeutics Stock Soared 137% in February
Mar 4 Biotech stocks are tracking for their best quarter ever — here's how to play it
Mar 4 MERGER ALERT – LABL and ONCE: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
Mar 1 Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices
Mar 1 [$$] The Side Effects of Million-Dollar Drugs
Feb 27 Biotech Stock Roundup: ONCE, CMTA Soar on Merger News, Other Pipeline Updates
Feb 27 A Look at Spark’s Potential Revenue Contribution to Roche Holdings
Feb 27 The Zacks Analyst Blog Highlights: Spark Therapeutics, Solid Biosciences, REGENXBIO, Editas Medicine and uniQure
Feb 27 What Analysts Are Recommending for Roche and Spark Therapeutics
Feb 27 Benzinga's Top Upgrades, Downgrades For February 27, 2019
Feb 27 Roche Holdings to Acquire Spark Therapeutics
Feb 27 BofA/ML cuts view on Karyopharm in premarket analyst action
Feb 26 MERGER ALERT – LABL, CMTA and ONCE: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies

Back to the Main ONCE Page...